• Services
    • Sell a company
      • Sell a company
      • Capital Raising
      • Company Valuation
      • Alternative Financing
      • Value Growth Consulting
      • Ready4Exit
    • Buy a Company
      • Buy a Company
      • Alternative Financing
      • Company Valuation
      • Market Intel service
      • Corporate Venturing
  • M&A Academy
    • Sell a company
    • Buy a company
    • Business Valuation
    • Investor Search
    • Alternative financing
    • Ready4Exit
  • Sectors
    • Enterprise Software
      • SW App
      • HR Software
      • Communications
      • ERP
      • CRM
      • Document Management
      • Vendor Partners (Salesforce, Microsoft, Sage, Amazon, Google, SAP)
      • CMMS
      • EHS
    • Digital Media / Advertising
      • Media & Entertainment
      • Gaming
      • Social Media
      • VR
      • AR
      • Agency & Marketing
      • Digital Health
      • MarTech
      • Creative Agency
    • Digital Services
      • Digital Transformation
      • Information technology
      • Digital BPO
      • IT Consultancy
      • Software Development
      • RPA
      • Market Research
      • Cybersecurity
    • Data / ML / AI
      • Analytics
      • Big Data
      • Machine Learning
      • Artificial Intelligence
      • Data Governance
    • Industrial Tech
      • Industrial Automation
      • IoT
      • Infrastructure Technology
      • MES
      • SCADA
    • EdTech
      • Corporate Training
      • eLearning
      • Education Platforms
      • LMS
    • Consumer Software
      • E-Commerce
      • Marketplaces
      • Computing
    • FinTech
      • Payments
      • Wealth Tech
      • Insure Tech
  • Insights & News
    • News and Trends
    • Industrial Reports
    • Transactions
    • Valuation Reports
    • Webinars
  • Contact
  • Other services
  • EN
    • ES

ABILITY PHARMACEUTICALS RAISES €3.5M TO LICENSE ONCOLOGY DRUG

25 September 2019 | Sector Funding

Ability Pharmaceuticals has just raised €3.5m to finalise the current Phase 2 oncology trial, and licence its drug ABTL0812 to an international pharmaceutical company for its development and future commercialisation. Clinical trials are the opportunity that...
DEVICARE RAISES €1.6M, THE LARGEST HEALTHCARE CROWDFUNDING ROUND IN SPAIN

DEVICARE RAISES €1.6M, THE LARGEST HEALTHCARE CROWDFUNDING ROUND IN SPAIN

19 July 2019 | Sector Funding

Devicare, belonging to the healthcare sector, has developed an innovative solution for the treatment of kidney stones. We analyse the recent €1.6m funding round it has closed, as well as other relevant corporate transactions in the sector. DEVICARE Devicare is...

Verse, the fintech of young people, raises €7M

5 July 2019 | Sector Funding

Corporate finance is experiencing the emergence of Fintech with particular intensity. The backing that this sector has from the new generations, as well as its continuous capital-raising needs, has caused funding rounds to...
Reinventing the Real Estate sector through investment

Reinventing the Real Estate sector through investment

15 May 2019 | Sector Funding

The real estate market has grown to pre-crisis levels, prices are increasingly higher and even rents have been affected by quite substantial rises. Interest in this productive sector has returned to pre-crisis levels,...

Biotech company DNActive receives a €372,500 round of funding

22 Mar 2019 | Sector Funding

The Granada-based company DNActive, which specialises in the development of genetic tests and the manufacture of products based on patients' genetics, has recently received a funding round. Its investor was the crowdfunding platform...
Page 3 of 17"12345...10..."Last »

Last Entries

  • november webinar
    Webinar | How much does your business depend on you?21/10/2026
  • transacciones m&a septiembre
    Notable technology M&A deals in Spain | September 2026 Analysis13/10/2026
  • Baker Tilly advises Invelon on the acquisition of byAR
    Baker Tilly advises Invelon on the acquisition of byAR08/10/2026
  • studibo acquires ingho
    INGHO is being integrated into Studibo with advice from Baker Tilly07/10/2026
  • studibo acquires valladares
    Studibo and IceLake acquire Valladares Ingeniería with advice from Baker Tilly17/09/2026

Request for information

If you want to buy or sell a company, or need more information about our services, do not hesitate to contact us through the form.

Or if you prefer, call us:

Phone icon +34 667 50 11 82
Call now



    Phone icon +34 667 50 11 82 (Switchboard)
    Place icon Las Mercedes Kalea, 25 - 48930 Getxo BIZKAIA
    Place icon Paseo de la Castellana, 91, plantas 14ª y 5ª - 28046 MADRID
    Place icon Av. de Josep Tarradellas, 123
    Les Corts - 08029 BARCELONA

    Services

    Sell a company

    Buy a company

    Search for investors and
    capital increase

    Business Valuation

    Alternative Financing

    Value Growth Consulting

    Market Intel service

    Corporate Venturing

    Insights & News

    News

    Industrial Reports

    Transactions

    Webinars

    Valuation reports

    Meet us

    Team

    • Follow
    • Follow
    • Follow

    Now, for tomorrow

    Work at Baker Tilly
    Privacy Policy | Ethical Channel for Complaints, Information and Communications | General Information | Anti-Bribery and Anti-Corruption Policy | Transparency reports

    ©2026 Baker Tilly (Spanien) ist ein unabhängiges Mitglied von Baker Tilly International. Baker Tilly International Limited ist ein englisches Unternehmen. Baker Tilly International erbringt keine professionellen Dienstleistungen für seine Kunden.